Thomas W. Rice, MD, Hemant Ishwaran, PhD, Mark K

Slides:



Advertisements
Similar presentations
Esophagus, Esophagus GE Junction, Stomach
Advertisements

Thymus, Trachea & Oesophagus
Staging of Esophageal Cancer. A major change between the 2002 and the 2010 TNM staging system is the development of separate stage groupings according.
ESOPHAGUS & STOMACH By Prof. Saeed Abuel Makarem.
Dr. Ahmed Fathalla Ibrahim
Lung Anatomic subsites of the lung. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer, ©American.
Practical 4 Functional anatomy of esophagus and stomach.
IMAGING FINDINGS - The NSCLC stage classification is based on the TNM system: - T: extent of the primary tumor - N: extent of regional lymph node involvement.
Case 1. Diagnosis : Stomach, resection margin, proximal, FS-1, biopsy: No tumor Stomach, resection margin, distal, FS-2, biopsy: Adenocarcinoma Lymph.
MEDIASTINUM. MEDIASTINUM DEFINITION OF MEDIASTINUM It is a partition between the right & left pleural sacs. It includes all the structures which lie.
A Hole in the Heart Journal of Thoracic Oncology
Ricardo L. Oliveira, MD, Moishe Liberman, MD, PhD 
Computed tomographic atlas for the new international lymph node map for lung cancer: A radiation oncologist perspective  Rod Lynch, MBBS, FRANZCR, Graham.
Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma  Yingjie.
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Primary Mucoepidermoid Carcinoma of the Esophagus
Targeted lymph node assessment in gastrointestinal neoplasms
ESOPHAGUS and STOMACH Ass. Prof. Dr. Saif Ali Ahmed Ghabisha.
The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification.
Resection and Mediastinal Lymph Node Dissection
Computed tomographic atlas for the new international lymph node map for lung cancer: A radiation oncologist perspective  Rod Lynch, MBBS, FRANZCR, Graham.
A cancer staging primer: Lung
Mediastinum: Sternal angle angle Lower border of T4
PET/CT Fusion Scan in Lung Cancer: Current Recommendations and Innovations  Cristina Gámez, MD, PhD, Rafael Rosell, MD, PhD, Alejandro Fernández, MD, PhD,
An unusual presentation of esophageal metastasis from breast cancer
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Marcin Zieliński, MD, PhD 
Resectable Clinical N2 Non–Small Cell Lung Cancer; What Is the Optimal Treatment Strategy? An Update by the British Thoracic Society Lung Cancer Specialist.
A cancer staging primer: Esophagus and esophagogastric junction
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Endoscopic and Endobronchial Ultrasonography According to the Proposed Lymph Node Map Definition in the Seventh Edition of the Tumor, Node, Metastasis.
Adenocarcinoma arising from cervical esophageal gastric inlet patch
Survival of patients with distal esophageal and gastric cardia tumors: A population- based analysis of gastroesophageal junction carcinomas  Bryan A. Whitson,
The Case of the Missed Chest Radiograph: Bilateral Mammary Gland Metastases Mimicking Multifocal Primary Breast Cancer as the Initial Manifestation of.
Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy  John J. Nigro, MD, Steven R. DeMeester, MD, Jeffrey A. Hagen,
ESOPHAGEAL CANCER BY :BILAL HUSSEIN.
Radical En Bloc Esophagectomy for Carcinoma of the Esophagus
KRAS Mutation Analysis Helps to Differentiate Between Pulmonary Metastasis from Colon Adenocarcinoma In Situ and Primary Lung Adenocarcinoma  Taylor M.
The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer  Ramón Rami-Porta, MD, FETCS,
Review on Management of Gastro-esophageal Junction Cancer
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
Transesophageal Ultrasonography for Lung Cancer Staging: Learning Curves of Pulmonologists  Lars Konge, MD, PhD, Jouke Annema, MD, PhD, Peter Vilmann,
Optimal Extent of Lymph Node Dissection for Siewert Type II Esophagogastric Junction Adenocarcinoma  Jun Peng, MD, Wen-Ping Wang, MD, Yong Yuan, MD, Yang.
The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 
Esophageal Carcinoma: Depth of Tumor Invasion Is Predictive of Regional Lymph Node Status 1  Thomas W Rice, Gregory Zuccaro, David J Adelstein, Lisa A.
M Zieliński, MD, R Rami-Porta, MD  Journal of Thoracic Oncology 
The normal configuration and interindividual differences in intramural lymphatic vessels of the esophagus  Shinji Yajin, MD, Gen Murakami, MD, PhD, Hiromi.
Esophageal Ultrasound-Controlled Fine Needle Aspiration for Staging of Mediastinal Lymph Nodes in Patients with Resectable Lung Cancer: Do We Always See.
Primary Mucoepidermoid Carcinoma of the Esophagus
Ricardo L. Oliveira, MD, Moishe Liberman, MD, PhD 
Proposed Modification of Nodal Status in AJCC Esophageal Cancer Staging System  Wayne Hofstetter, MD, Arlene M. Correa, PhD, Neby Bekele, PhD, Jaffer A.
A Hole in the Heart Journal of Thoracic Oncology
Anatomy of Esophagus & stomach
Explore the Radiotherapeutic Clinical Target Volume Delineation for Thoracic Esophageal Squamous Cell Carcinoma from the Pattern of Lymphatic Metastases 
Hideo Ichimura, MD, Shinji Kikuchi, MD, Hiroichi Ishikawa, MD 
Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma  Yingjie.
ALK Translocation in Non-small Cell Lung Cancer with Adenocarcinoma and Squamous Cell Carcinoma Markers  Samuel J. Klempner, MD, David W. Cohen, MD, Daniel.
Renal Cell Carcinoma Lung Metastases Surgery: Pathologic Findings and Prognostic Factors  Jalal Assouad, MD, Boriana Petkova, MD, Pascal Berna, MD, Antoine.
Multiple Primary Cancers or Multiple Metastases, That Is the Question
Frequency and Prognostic Significance of Preoperatively Detected Enlarged Regional Lymph Nodes in Patients with Pathological Stage I Non-small Cell Lung.
It’s All in the “Swerve of the Curve”
A Critique of the International Association for the Study of Lung Cancer Lymph Node Map: A Radiation Oncology Perspective  Graham Pitson, MBBS, FRANZCR,
Prof. Ahmed Fathalla Ibrahim
LE Right lung Left lung O2 9. CO2 10.
Thoracic duct tributaries from intrathoracic organs
MEDIASINUM Dr Jamila EL medany.
Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non–Small Cell Lung Cancer 
Transesophageal Ultrasonography for Lung Cancer Staging: Learning Curves of Pulmonologists  Lars Konge, MD, PhD, Jouke Annema, MD, PhD, Peter Vilmann,
Patterns-of-Care for Thoracic Stereotactic Body Radiotherapy among Practicing Radiation Oncologists in the United States  Megan E. Daly, MD, Julian R.
Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography  Kwhanmien Kim, MD, Seung Joon Park,
Presentation transcript:

Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer  Thomas W. Rice, MD, Hemant Ishwaran, PhD, Mark K. Ferguson, MD, Eugene H. Blackstone, MD, Peter Goldstraw, MD  Journal of Thoracic Oncology  Volume 12, Issue 1, Pages 36-42 (January 2017) DOI: 10.1016/j.jtho.2016.10.016 Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Eighth edition TNM categories. T is categorized as Tis: high-grade dysplasia (HGD). T1 is cancer that invades the lamina propria, muscularis mucosae, or submucosa and is subcategorized into T1a (cancer that invades the lamina propria or muscularis mucosae) and T1b (cancer that invades the submucosa); T2 is cancer that invades the muscularis propria; T3 is cancer that invades the adventitia; T4 is cancer that invades the local structures and is subcategorized as T4a (cancer that invades adjacent structures such as the pleura, pericardium, azygos vein, diaphragm, or peritoneum) and T4b (cancer that invades the major adjacent structures, such as the aorta, vertebral body, or trachea). N is categorized as N0 (no regional lymph node metastasis), N1 (regional lymph node metastases involving one to two nodes), N2 (regional lymph node metastases involving three to six nodes), and N3 (regional lymph node metastases involving seven or more nodes). M is categorized as M0 (no distant metastasis) and M1 (distant metastasis). Journal of Thoracic Oncology 2017 12, 36-42DOI: (10.1016/j.jtho.2016.10.016) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2 Lymph node maps for esophageal cancer. Regional lymph node stations for staging esophageal cancer from the left (A), right (B), and anterior (C). 1R, right lower cervical paratracheal nodes, between the supraclavicular paratracheal space and apex of the lung; 1L, left lower cervical paratracheal nodes, between the supraclavicular paratracheal space and apex of the lung; 2R, right upper paratracheal nodes, between the intersection of the caudal margin of the brachiocephalic artery with the trachea and apex of the lung; 2L, left upper paratracheal nodes, between the top of the aortic arch and apex of the lung; 4R, right lower paratracheal nodes, between the intersection of the caudal margin of the brachiocephalic artery with the trachea and cephalic border of the azygos vein; 4L, left lower paratracheal nodes, between the top of the aortic arch and the carina; 7, subcarinal nodes, caudal to the carina of the trachea; 8U, upper thoracic paraesophageal lymph nodes, from the apex of the lung to the tracheal bifurcation; 8M, middle thoracic paraesophageal lymph nodes, from the tracheal bifurcation to the caudal margin of the inferior pulmonary vein; 8Lo, lower thoracic paraesophageal lymph nodes, from the caudal margin of the inferior pulmonary vein to the esophagogastric junction; 9R, pulmonary ligament nodes, within the right inferior pulmonary ligament; 9L, pulmonary ligament nodes, within the left inferior pulmonary ligament; 15, diaphragmatic nodes, lying on the dome of the diaphragm and adjacent to or behind its crura; 16, paracardial nodes, immediately adjacent to the gastroesophageal junction; 17, left gastric nodes, along the course of the left gastric artery; 18, common hepatic nodes, immediately on the proximal common hepatic artery; 19, splenic nodes, immediately on the proximal splenic artery; 20, celiac nodes, at the base of the celiac artery. Cervical periesophageal level VI and level VII lymph nodes are named as per the head and neck map. Journal of Thoracic Oncology 2017 12, 36-42DOI: (10.1016/j.jtho.2016.10.016) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

Figure 3 Location of esophageal cancer primary site, including typical endoscopic measurements of each region measured from the incisors. Exact measurements depend on body size and height. Location of cancer primary site is defined by cancer epicenter. Cancers involving the esophagogastric junction (EGJ) that have their epicenter within the proximal 2 cm of the cardia (Siewert types I/II) are to be staged as esophageal cancers. Cancers whose epicenter is more than 2 cm distal from the EGJ, even if the EGJ is involved, will be staged using the stomach cancer TNM and stage groups. LES, lower esophageal sphincter; UES, upper esophageal sphincter. Journal of Thoracic Oncology 2017 12, 36-42DOI: (10.1016/j.jtho.2016.10.016) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

Figure 4 (A) Pathologic stage groups (pTNM): adenocarcinoma. (B) Pathologic stage groups (pTNM): squamous cell carcinoma. Journal of Thoracic Oncology 2017 12, 36-42DOI: (10.1016/j.jtho.2016.10.016) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

Figure 5 Postneoadjuvant pathologic stage groups (ypTNM): adenocarcinoma and squamous cell carcinoma. Journal of Thoracic Oncology 2017 12, 36-42DOI: (10.1016/j.jtho.2016.10.016) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

Figure 6 (A) Clinical stage groups (cTNM): adenocarcinoma. (B) Clinical stage groups (cTNM): squamous cell carcinoma. Journal of Thoracic Oncology 2017 12, 36-42DOI: (10.1016/j.jtho.2016.10.016) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions